MGEA5 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.225800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.105600E-01
Normal-vs-Stage2
4.287200E-01
Normal-vs-Stage3
3.430000E-01
Normal-vs-Stage4
4.175800E-01
Stage1-vs-Stage2
7.842800E-01
Stage1-vs-Stage3
1.664820E-01
Stage1-vs-Stage4
9.298400E-01
Stage2-vs-Stage3
2.479600E-01
Stage2-vs-Stage4
8.677200E-01
Stage3-vs-Stage4
2.754600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.277600E-01
Normal-vs-AfricanAmerican
3.891000E-01
Normal-vs-Asian
3.804400E-01
Caucasian-vs-AfricanAmerican
5.243600E-01
Caucasian-vs-Asian
3.173000E-01
AfricanAmerican-vs-Asian
9.054800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.304800E-01
Normal-vs-Female
4.137400E-01
Male-vs-Female
4.912200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.941600E-01
Normal-vs-Age(41-60Yrs)
4.638000E-01
Normal-vs-Age(61-80Yrs)
4.061800E-01
Normal-vs-Age(81-100Yrs)
4.004200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.329400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.968600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.993800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.241500E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.710400E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.276200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.209600E-01
Normal-vs-Daily Drinker
4.409000E-01
Normal-vs-Weekly Drinker
3.753400E-01
Normal-vs-Occasional Drinker
4.592400E-01
Normal-vs-Social Drinker
4.296000E-01
Non Drinker-vs-Daily Drinker
6.865000E-01
Non Drinker-vs-Weekly Drinker
3.394000E-01
Non Drinker-vs-Occasional Drinker
4.686000E-01
Non Drinker-vs-Social Drinker
8.715000E-01
Daily Drinker-vs-Weekly Drinker
2.091400E-01
Daily Drinker-vs-Occasional Drinker
7.487200E-01
Daily Drinker-vs-Social Drinker
8.357000E-01
Weekly Drinker-vs-Occasional Drinker
1.246640E-01
Weekly Drinker-vs-Social Drinker
2.715400E-01
Occasional Drinker-vs-Social Drinker
6.037000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.239600E-02
Normal-vs-Grade 2
3.798200E-03
Normal-vs-Grade 3
3.197700E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.389800E-01
Grade 1-vs-Grade 3
1.533370E-01
Grade 1-vs-Grade 4
6.239600E-02
Grade 2-vs-Grade 3
3.118400E-01
Grade 2-vs-Grade 4
3.798200E-03
Grade 3-vs-Grade 4
3.197700E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.272400E-01
Normal-vs-NonDiabetic
4.177000E-01
Diabetic-vs-NonDiabetic
7.616400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.871800E-01
Normal-vs-NoPancreatitis
4.134800E-01
Pancreatitis-vs-NoPancreatitis
1.490830E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.272600E-01
Normal-vs-N1
4.221800E-01
N0-vs-N1
8.653800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.708000E-01
Normal-vs-TP53-NonMutant
4.207600E-01
TP53-Mutant-vs-TP53-NonMutant
1.819350E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
